synthesized in the liver, is responsible for about 9000 of the inhibitory capacity of human serum for trypsin, and also for the inhibition of other proteolytic enzymes such as elastase, collagenase and leucocyte proteases. Synthesis of AAT is controlled by a pair of genes at one locus for which as many as 24 alleles have been described. These alleles are inherited in an autosomal codominant manner. They are responsible for the different structural variants of the AAT molecule, which can be detected by their different electrophoretic mobilities. The Z, or slowest variantt, in either its homozygous or heterozygous form, may be the cause of a deficiency of AAT in the serum.
AAT deficiency has been shown to be associated with a variety of diseases, but particularly with chronic obstructive pulmonary disease (Ganrot et al., 1967) and liver disease (Berg and Eriksson, 1972; Feldman et al., 1974; Sharp, 1976) . The latter takes the form of cholestatic jaundice in infancy (neonatal hepatitis), childhood cirrhosis and, less often, cirrhosis in adults. In addition, a few cases of hepatocellular (11CC) or cholangiocellular cancer have been described in patients with homozygous (ZZ) or heterozygous (MZ) AAT deficiency (Ganrot et al., 1967; Accepted 29 December 1977 Berg and Eriksson, 1972; Eriksson and Hiagerstrand, 1974; Aagenaes et al., 1974; Lieberman, 1974; Rawlings, et al., 1974; Williams and Fajardo, 1974; Lieberman et al., 1975; Zwi et al., 1975) . A characteristic finding in individuals with both homozygous or heterozygous AAT deficiency, in the presence or absence of liver disease, is the accumulation of periodic acid-Schiff (PAS)-positive, diastase-resistant globules in periportal hepatocytes (Sharp, 1971) . These globules consist of aggregates of an asialo-antitrypsin within the dilated endoplasmic reticulum (Eriksson and Larsson, 1975) .
The frequency with which AAT deficiency predisposes to HCC, if indeed it does so, is not known. In 2 retrospective studies (Norkin and Campagna-Pinto, 1968; Berg and Eriksson, 1972) I AAT subtypes are designated by letters according to their electrophoretic mobility, as F (fast), M (medium), S (slow) and Z (ultra slow). For details, see Fagerhol (1976) .
phenotypes by acid-starch electrophoresis, and looked for PAS-positive diastaseresistant globules in the livers and tumours of a series of southern African blacks with HCC.
Seventy-seven unselected adult black patients with histologically proven HCC were studied. All but 4 of the patients were males. Blood was taken at the time of diagnosis and before treatment was begun. STIC was measured by the benzoylarginine-p-nitroanilide method of Erlanger et al. (1961) in 60 patients and serum AAT concentrations by RID (Schulman, 1973) in the remaining 17 patients. AAT phenotyping was determined in all patients by acid-starch electrophoresis as described by Fagerhol (1968) . Non-tumorous liver tissue (normal or cirrhotic) and tumour tissue obtained from each patient either by percutaneous biopsy or at laparotomy or necropsy were stained with PAS after treatment with diastase and counterstained with haematoxylin. All the slides were prepared by one technician in a single session. A section from the liver of a patient with proven AAT deficiency and known to have PAS-positive diastaseresistant globules in the hepatocytes was included with the other slides as a control. The sections were then examined for PASpositive inclusion globules. In patients with H1CC and AAT deficiency, PASpositive diastase-resistant globules are found in the malignant hepatocytes as well as in the non-tumorous liver tissue (Lieberman et al., 1975 (Prinsloo and Turnbull, unpublished) .
In none of the HCC patients were intracytoplasmic PAS-positive, diastaseresistant globules observed, either in nontumorous liver tissue or in the tumour.
In a prospective study using chemical, electrophoretic and histological criteria, we could find no case of AAT deficiency in 77 unselected black patients with HCC. It is therefore highly unlikely that AAT deficiency plays a major role in the aetiology of this tumour, which occurs so commonly in southern African blacks. Our findings are at variance with those of Berg and Eriksson (1972) and Norkin and Campagna-Pinto (1968) , the former studying European and the latter American patients. There are 2 possible explanations for this. Firstly, the PAS-positive globules in the livers of their patients may have consisted of some substance other than AAT in the cytoplasm of the hepatocytes (Dekker and Krause, 1973; Palmer et al., 1974) . To be certain that these globules contain AAT, it is necessary to use either a specific immunofluorescent technique on the tissues, using fluoresceinlabelled anti-human AAT (Delellis et al., 1972) or the immunoperoxidase method (Palmer and Wolfe, 1976 As we did not perform crossed-electrophoresis in phenotyping our patients, it may be argued that heterozygote Z phenotypes might have been missed. The results of the chemical and histological studies make this unlikely. Lieberman and his coworkers (1975) have seen only one MZ patient with an STIC greater than 1-3 mg trypsin inhibited per ml of serum and this was found shortly after a partial hepatectomy had been performed. All but 2 of our patients had STIC or AAT concentrations by RID above the upper limit of normal, and it is doubtful that a MZ or even a FZ phenotype would have achieved these levels. PAS-positive diastase-resistant globules were present in all of Eriksson and Hagerstrand's large series of patients with AAT deficiency (Eriksson and Hagerstrand, 1974) . These globules were not demonstrable in the 2 patients in the present series with normal serum AAT concentrations or, indeed, in any of the patients.
With 2 exceptions, our patients had high AAT levels. AAT concentrations are known to rise in the blood during the course of malignant disease (Clark et al., 1948) . It has been suggested that the increase in AAT is an attempt by the body to defend itself against the spread and progression of cancer (Goetz et al., 1972; O'Neill, 1974) . Were this so, individuals with AAT deficiency might be expected to have an increased susceptibility to all forms of malignancy, and not only to HCC.
Alternatively, high AAT values might simply reflect a non-specific acute-phase response to tissue injury or inflammation.
